You have 9 free searches left this month | for more free features.

mm-121

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Colorectal Cancer, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (MM-151, MM-121, MM-141)

Terminated
  • Colorectal Cancer
  • +2 more
  • Aurora, Colorado
  • +4 more
Aug 31, 2017

Solid Tumors Trial in France, United States (MM-121, Carboplatin, Pemetrexed)

Completed
  • Solid Tumors
  • MM-121
  • +4 more
  • Lafayette, Indiana
  • +4 more
Sep 13, 2016

Colorectal Cancer, Squamous Cell Head Neck Cancer, NSCLC Trial in United States (MM-121, Irinotecan, Cetuximab)

Completed
  • Colorectal Cancer
  • +4 more
  • MM-121
  • +2 more
  • San Francisco, California
  • +3 more
Sep 6, 2016

Advanced Solid Tumors Trial in Boston, Philadelphia, Nashville, (MM-121)

Completed
  • Advanced Solid Tumors
  • MM-121
  • Boston, Massachusetts
  • +2 more
Aug 30, 2016

Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial

Completed
  • Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,
  • +2 more
  • Birmingham, Alabama
  • +4 more
Sep 6, 2016

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (MM-121, Paclitaxel)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Glendale, Arizona
  • +9 more
Apr 11, 2016

Her2 Negative Breast Cancer Patients Trial in Worldwide (MM-121, Placebo, Exemestane)

Completed
  • Her2 Negative Breast Cancer Patients
  • MM-121
  • +2 more
  • Birmingham, Alabama
  • +32 more
Apr 11, 2016

ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients Trial in United States (MM-121,

Completed
  • ER Positive, Her2 Negative Breast Cancer Patients
  • Triple Negative Breast Cancer Patients
  • Birmingham, Alabama
  • +37 more
Mar 30, 2016